Literature DB >> 22670886

A study of the chemical and biological stability of vasoactive intestinal peptide.

Xu Cui1, Deying Cao, Changhai Qu, Xiaoyan Zhang, Aiping Zheng.   

Abstract

CONTEXT: Vasoactive intestinal peptide (VIP) is a linear cationic neuropeptide composed of 28 amino acids. It belongs to the glucagon/secretin family. The biological functions of VIP are relatively broad, but it has not been well studied in the field of pharmaceutics. Especially in the selection of the way of VIP administration and the pharmaceutical formulation, the theory basis was deficient appreciably.
OBJECTIVE: To provide the theory basis for the pharmaceutical development of VIP, the chemical and biological stability of VIP was studied.
MATERIALS AND METHODS: The stability of VIP in different pH values, ionic strength, temperature, artificial gastric fluid and artificial intestinal fluid was investigated, and the concentration of VIP was calculated by HPLC method.
RESULTS: The stability of VIP was pH-dependent. VIP was stable in acid and neutral solution, and almost didn't degrade during pH ≤ 7 solution. However, it was instability in basic solution and degraded completely at 30 min in pH 13 solution. Ionic strength did not affect its stability. VIP was stable in freezing conditions but it degraded at low concentration in cold storage. Furthermore, VIP degraded so quickly in artificial gastric fluid and artificial intestinal fluid that it can't be detected at 0 min. DISCUSSION AND
CONCLUSION: the chemical and biological characteristic of VIP was unstable, so it isn't suitable for oral administration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670886     DOI: 10.3109/03639045.2012.693503

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

Review 1.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

2.  Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule.

Authors:  Shubha Priyamvada; Anoop Kumar; Seema Saksena; Hayat Onyuksel
Journal:  Nanomedicine (Lond)       Date:  2020-09-25       Impact factor: 5.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.